Cell biology

Durin Technologies, Inc., Appoints CEO

Retrieved on: 
Wednesday, November 22, 2023

Durin Technologies, Inc., an innovator in neurodegenerative disease diagnostic test development and commercialization, today announced the appointment of Dr. Mert Sahin as Chief Executive Officer.

Key Points: 
  • Durin Technologies, Inc., an innovator in neurodegenerative disease diagnostic test development and commercialization, today announced the appointment of Dr. Mert Sahin as Chief Executive Officer.
  • View the full release here: https://www.businesswire.com/news/home/20231122887173/en/
    Mert Sahin, PhD Joins Durin Technologies as CEO.
  • (Photo: Business Wire)
    Dr. Sahin is a highly accomplished business executive with an impressive track record of success in the life sciences sector.
  • He brings to Durin more than 20 years of experience in life sciences, pharmaceuticals, and medical devices, where he has demonstrated expertise in formulating and executing strategic go-to-market plans resulting in exceptional growth.

Deepcell Garners Industry Recognition for Disruptive AI-Driven Approach to Single Cell Morphology Analysis

Retrieved on: 
Tuesday, November 14, 2023

Deepcell , a pioneer in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoveries, today shared the news of two significant industry recognitions as it prepares for upcoming scientific meetings.

Key Points: 
  • Deepcell , a pioneer in artificial intelligence (AI)-powered single-cell analysis to fuel deep biological discoveries, today shared the news of two significant industry recognitions as it prepares for upcoming scientific meetings.
  • Earlier this year, Deepcell launched the REM-I platform , a high-dimensional cell morphology analysis and sorting platform which comprises the REM-I benchtop instrument, Human Foundation Model, and Axon data suite.
  • By bringing together single cell imaging, sorting, and high-dimensional analysis, the REM-I platform catalyzes new methods of discovery in a wide range of fields including cancer biology, developmental biology, stem cell biology, gene therapy and functional screening, among others.
  • Deepcell’s REM-I platform was selected as "Cell Imaging Product of the Year," one of only four breakthrough innovations in the field of cell biology, in the third annual BioTech Breakthrough Awards.

4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts

Retrieved on: 
Friday, November 10, 2023

4Moving Biotech, a subsidiary of 4P-Pharma, announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial.

Key Points: 
  • 4Moving Biotech, a subsidiary of 4P-Pharma, announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate's phase 2b clinical trial.
  • Professor Francis Berenbaum, CMO of 4Moving Biotech, will lead the work of this scientific advisory board.
  • The Scientific Advisory Board will bring deep knowledge and experience from clinical research, academia, and industry to better serve people suffering from knee osteoarthritis.
  • 4Moving Biotech has responded to this challenge with an innovative research program to explore the potential of intra-articular GLP-1 analogs for knee osteoarthritis treatment.

Stem Cell Therapy Contract Manufacturing Market Report 2023-2033 - Advances in Cell Biology and Regenerative Medicine Propels Stem Cell Therapy Market

Retrieved on: 
Thursday, December 14, 2023

DUBLIN, Dec. 14, 2023 /PRNewswire/ -- The "Stem Cell Therapy Contract Manufacturing Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 14, 2023 /PRNewswire/ -- The "Stem Cell Therapy Contract Manufacturing Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • In an insightful new research publication, the burgeoning stem cell therapy contract manufacturing market is analyzed in extensive detail, projecting a surpassing of US$2.75 billion in value for the year 2023 alone.
  • The latest findings highlight the rapid evolution of the stem cell therapy contract manufacturing market, bolstered by advances in cell biology and regenerative medicine.
  • The report presents granular forecasts spanning numerous market segments including scale of operation, size of contract manufacturer, and stem cell types, among others.

Cells Move in Groups Differently Than They Do When Alone

Retrieved on: 
Wednesday, December 13, 2023

NEW YORK, Dec. 13, 2023 /PRNewswire/ -- A protein that helps generate the force needed for single cells to move works differently in cells moving in groups, a new study shows.

Key Points: 
  • NEW YORK, Dec. 13, 2023 /PRNewswire/ -- A protein that helps generate the force needed for single cells to move works differently in cells moving in groups, a new study shows.
  • Zebrafish are a major model in the study of development because they are transparent and share cellular mechanisms with humans.
  • The current study found that the cells in the primordium instead activate RhoA in pulses in the front of the cells where it does two jobs.
  • "The machinery suggests that the movement of single cells and groups of cells is similar, but that RhoA contributes to that machinery differently in each case.

Live Cell Imaging Market to Reach $5.2 Billion, Globally, by 2032 at 8.2% CAGR: Allied Market Research

Retrieved on: 
Tuesday, December 12, 2023

PORTLAND, Ore., Dec. 12, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Live Cell Imaging Market by Product Type (Instruments, Accessories and Consumables and Software), Application (Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery), Technology (Time-lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High-Content Screening (HCS), and Other Technologies) and End User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032". According to the report, the global live cell imaging industry generated $2.3 billion in 2022 and is anticipated to generate $5.2 billion by 2032, witnessing a CAGR of 8.2% from 2023 to 2032.

Key Points: 
  • Moreover, it hampers investments in live cell imaging technology development, slowing down innovation and the introduction of advanced imaging systems.
  • Diseases and health concerns persist regardless of economic conditions, potentially leading to sustained demand for live cell imaging technologies in critical areas such as disease research, diagnostics, and drug development.
  • This is attributed to increase in funding allocations research studies, promoting adoption of advanced live cell imaging technologies for varied biological studies.
  • In addition, robust funding environment, coupled with supportive government initiatives, has propelled the adoption of innovative imaging techniques such as live cell imaging in academic and research institutions.

Live Cell Imaging Market to Reach $5.2 Billion, Globally, by 2032 at 8.2% CAGR: Allied Market Research

Retrieved on: 
Tuesday, December 12, 2023

PORTLAND, Ore., Dec. 12, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Live Cell Imaging Market by Product Type (Instruments, Accessories and Consumables and Software), Application (Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery), Technology (Time-lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High-Content Screening (HCS), and Other Technologies) and End User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032". According to the report, the global live cell imaging industry generated $2.3 billion in 2022 and is anticipated to generate $5.2 billion by 2032, witnessing a CAGR of 8.2% from 2023 to 2032.

Key Points: 
  • Moreover, it hampers investments in live cell imaging technology development, slowing down innovation and the introduction of advanced imaging systems.
  • Diseases and health concerns persist regardless of economic conditions, potentially leading to sustained demand for live cell imaging technologies in critical areas such as disease research, diagnostics, and drug development.
  • This is attributed to increase in funding allocations research studies, promoting adoption of advanced live cell imaging technologies for varied biological studies.
  • In addition, robust funding environment, coupled with supportive government initiatives, has propelled the adoption of innovative imaging techniques such as live cell imaging in academic and research institutions.

Microcarriers Market Worth $3.3 Billion | MarketsandMarkets

Retrieved on: 
Wednesday, December 6, 2023

Consumables accounted for the major market share of microcarriers market in 2022.

Key Points: 
  • Consumables accounted for the major market share of microcarriers market in 2022.
  • Additionally, the growing R&D activities in the biotechnology sector are promoting the growth of the microcarriers market.
  • Based on application, the microcarriers market has been segregated into biopharmaceutical production, tissue engineering and regenerative medicine, and other applications.
  • Microcarriers Market Size - Key Benefits of Buying the Report:
    The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall microcarriers market and its subsegments.

Microcarriers Market Worth $3.3 Billion | MarketsandMarkets

Retrieved on: 
Wednesday, December 6, 2023

Consumables accounted for the major market share of microcarriers market in 2022.

Key Points: 
  • Consumables accounted for the major market share of microcarriers market in 2022.
  • Additionally, the growing R&D activities in the biotechnology sector are promoting the growth of the microcarriers market.
  • Based on application, the microcarriers market has been segregated into biopharmaceutical production, tissue engineering and regenerative medicine, and other applications.
  • Microcarriers Market Size - Key Benefits of Buying the Report:
    The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall microcarriers market and its subsegments.

Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's

Retrieved on: 
Wednesday, December 6, 2023

NEW YORK, Dec. 6, 2023 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that its President and Chief Scientific Officer, Daniel Alkon, M.D., will join more than 30 leading neuroscientists and academics as a speaker at IABS Forum-2023, "New Concepts for the Treatment of Neurodegenerative Disorders." The distinguished scientific forum, to be held on December 7-8, 2023 in Irvine, CA, is co-sponsored by the University of Southern California School of Pharmacy and the International Association of Biomedical Sciences (IABS).

Key Points: 
  • The distinguished scientific forum, to be held on December 7-8, 2023 in Irvine, CA, is co-sponsored by the University of Southern California School of Pharmacy and the International Association of Biomedical Sciences (IABS).
  • The forum's keynote address, entitled "Towards a Cell Biology of Alzheimer's Disease," will be delivered by Dr. Thomas Südhof, Nobel Laureate in Physiology or Medicine 2013.
  • Dr. Südhof is known for his groundbreaking research on the mechanisms underlying synaptic transmission, which plays a vital role in learning, memory, and various neurological processes.
  • A research article detailing the results was published earlier this year in the Journal of Alzheimer's Disease.